Arisz Acquisition priced its IPO of 6 million units at $10 each. Units list on the Nasdaq and begin trading today under ARIZU. Each consists of one share of common stock, one right to receive one-twentieth of a share, and a warrant to purchase three-fourths of a share at $11.50 per whole share.
The offering is expected to close Nov. 22.
Arisz will focus on companies within the healthcare industry.
CEO and Chairwoman Echo Hindle-Yang in 2016 founded M.S.Q. Ventures, a New York-based advisory firm that focuses on integration for emerging life sciences companies.
Chardan is sole book-running manager of the offering. The underwriters may opt to purchase up to an additional 900,000 units. Read more.
